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Abstract Cultured endothelial cells of the human retina
and choroid demonstrate distinct patterns of gene expres-
sion. We hypothesized that differential gene expression
reflected differences in the interactions of transcription
factors and respective cis-regulatory motifs(s) in these two
endothelial cell subpopulations, recognizing that motifs
often exist as modules. We tested this hypothesis in silico
by using TRANSFAC Professional and CisModule to
identify cis-regulatory motifs and modules in genes that
were differentially expres s e db yh u m a nr e t i n a lv e r s u s
choroidal endothelial cells, as identified by analysis of a
microarray data set. Motifs corresponding to eight transcrip-
tion factors were significantly (p<0.05) differentially abun-
dant in genes that were relatively highly expressed in retinal
(i.e., glucocorticoid receptor, high mobility group AT-hook
1, heat shock transcription factor 1, p53, vitamin D receptor)
or choroidal (i.e., transcription factor E2F, Yin Yang 1, zinc
finger 5) endothelial cells. Predicted cis-regulatory modules
were quite different for these two groups of genes. Our
findings raise the possibility of exploiting specific cis-
regulatory motifs to target therapy at the ocular endothelial
cells subtypes responsible for neovascular age-related





within different extraocular vascular beds [1]. This phenom-
enon of “endothelial cell heterogeneity” [2] may also be
observed in the human eye. Using oligonucleotide micro-
arrays with probe sets for 8,746 transcripts, we demonstrated
that approximately 10% of genes were significantly differ-
entially expressed by donor-matched cultured human retinal
and choroidal endothelial cells [3]. Consistent with these
findings, we subsequently showed that protein expression
differed between human retinal and choroidal endothelial
cells; when retinal and choroidal endothelial protein extracts
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resis, 25% of the 123 protein spots that were analyzed
contained significantly different amounts of material derived
from the retinal versus choroidal endothelial cells [4].
Differential gene expression by ocular endothelial sub-
populations is likely controlled by multiple mechanisms
including the interaction of transcription factors with their
cis-regulatory motifs. Furthermore, it is expected that genes
with similar expression patterns would have common motifs.
This relationship is not simple, as gene expression is usually
controlled by combinations of transcription factors acting via
groups of cis-regulatory motifs, which are referred to as cis-
regulatory modules [5]. Nonetheless, this provides a mech-
anism whereby activity of one or more transcription factors
could result in cell type-specific expression of a subset of
genes. A corollary to this statement is that existence of
motifs or modules that are significantly more abundant in
genes preferentially expressed in one cell type implicates
activity of the respective transcription factor(s) in the
regulation of gene expression of that cell specifically.
New in silico methods provide one avenue for compar-
ing the regulation of gene expression between different cell
types (or different states of the same cell). Biostatistics
software programs that link to bioinformatics databases
allow the investigator to identify and compute the abun-
dance of cis-regulatory motifs or modules within the
promoter region of any given gene. TRANSFAC [6], a
database first conceived by Wingender [7] in 1988, is
arguably the most comprehensive and widely used assem-
bly of transcription factors and their respective cis-
regulatory elements and regulated genes, with built-in
search tools [8, 9]. CisModule is a recently published
algorithm, best described as a “Bayesian module sampler,”
that was developed for “discovery” of novel—or known—
cis-regulatory modules and constituent motifs [10]. Al-
though the literature does not contain published reports of
the application of this computational approach to the
investigation of human ocular endothelial cells, Waleev et
al. [11] used a similar approach to study changes in gene
regulation in human umbilical vein endothelial cells in
response to stimulation with tumor necrosis factor alpha
[12]. In this study, we performed analyses using TRANS-
FAC and CisModule to identify cis-regulatory elements and
modules in genes that were differentially expressed by
retinal versus choroidal endothelial cells.
Materials and methods
Gene expression microarray data
We analyzed a microarray data set that had been generated by
comparing gene expression of resting retinal and choroidal
endothelial cells from eyes of three human cadaver donors
using Affymetrix GeneChip Human Genome Focus Arrays
(two technical replicates/cell type/donor; technical replicates
were generated by preparing duplicate cultures of endothelial
cells, from which RNA was extracted separately for hybrid-
ization to independent arrays). These data may be found in the
Gene Expression Omnibus repository [13] (GSE7850: see
retinal/choroidal endothelial cell_human 4/5/6_unstimulate-
d_replicate1/2). Information about the experimental proce-
dure and data normalization and processing were previously
published [3]. Significant differences in gene expression
between retinal and choroidal endothelial cells were deter-
mined using the significance analysis of microarrays [14]
with the false discovery rate [15] set at 5%; transcripts
identified by this method were further filtered to select for
those that demonstrated a unidirectional and twofold or
greater change across all three donors. This filtering of the
data was performed to enrich the data set for genes that were
clearly differentially expressed by retinal and choroidal
endothelial cells, because genes that were not differentially
expressed were not expected to influence the analysis.
Alternative approaches would have been to study the entire
group of expressed genes, including genes that were not
differentially expressed, or a subset of these genes that had
been chosen at random. However, manual determination of
promoter sequences would have been impractical had we
taken either of these approaches. We preferred to determine
the promoter sequences manually (see “Collection of pro-
moter sequences”), as this allowed us to define the length and
position of the promoter sequence and, in addition, ensured
that the transcription start site (TSS) was correctly identified.
Collection of promoter sequences
Human gene sequences were identified on the nucleotide
website of the National Center for Biotechnology Informa-
tion [16]. For each gene, nucleotide sequences, including
2,000 bp of the 5′ flanking promoter region and 1,000 bp
downstream of the TSS, were collected. If a particular gene
encoded transcript variants with different TSSs, the defined
3,000 bp sequences for all variants were recorded.
Sequences were stored as text files, with the positions of
TSS, ATG start codon, exon(s), and intron(s) annotated.
Identification of cis-regulatory motifs
Before analysis of the promoter sequences, regions that
contained interspersed repeats or were of low complexity
were identified and masked using RepeatMasker [17]. The
modified sequences were evaluated for the presence and
abundance of known cis-regulatory motifs, using TRANS-
FAC Professional v11.4 (Biobase GmbH, Germany), with
Match, to perform a matrix-based search. For any motif
38 j ocul biol dis inform (2008) 1:37–45identified in this way, relative abundance was compared for
genes that were highly expressed in retinal versus choroidal
endothelial cells by the Fisher’s exact test, with a p value
below 0.05 defining a significant difference in abundance.
Identification of cis-regulatory modules
We used CisModule [18] to predict potential cis-regulatory
motifs and modules in the same modified promoter sequences
that were studied in the previous analysis. CisModule is based
on a hierarchical mixture model that recognizes the existence
of the cis-regulatory module as a series of transcription factor
binding sites within short genomic sequences and acting in
concert to regulate gene expression; the algorithm, which uses
Bayesian inference, involves simultaneous sampling of a
promoter sequence for both putative modules and motifs [10].
Consequently, CisModule may be employed to identify both
known and novel cis-regulatory elements and to predict cis-
regulatory modules, by analysis of a group of co-regulated
genes. We ran each set of promoter sequences separately
through CisModule a total of three times with parameters set
as follows: up to five motifs per module, motif length of 8 to
14 bp, and module length of up to 200 bp. The run with the
highest posterior model odds for each cell subtype was




In the gene expression data set, 73 and 66 transcripts of the
total of 8,746 transcripts represented on the array were
present at significantly higher levels in retinal and choroidal
endothelial cells, respectively. We retrieved genomic se-
quence encompassing 2,000 bp of the 5′ flanking promoter
region and 1,000 bp downstream of the TSS for 67 of the
73 genes that were highly expressed in retinal cells and 63
of the 66 genes that were highly expressed in choroidal
cells. As we also retrieved the sequences for any genes
encoding transcript isoforms with alternative TSSs, we
collected, in total, 91 and 76 promoter sequences
corresponding to gene transcripts that were present in
relative abundance in retinal and choroidal endothelial
cells, respectively. The differentially expressed genes are
identified in Supplementary Tables 1 and 2.
Comparison of cis-regulatory motifs in genes differentially
expressed by retinal and choroidal endothelial cells
The Match program of TRANSFAC Professional returned a
total of 5,756 cis-regulatory motifs, corresponding to 159
different transcription factors, from the 91 retinal endothe-
lial sequences, and a total of 4,973 cis-regulatory motifs
corresponding to 158 different transcription factors, from
the 76 choroidal endothelial sequences. To minimize
spurious identification of false motifs, we filtered our
search to identify only motifs with a “core match” of one;
for any given potential binding site of 7 to 15 bp, an
invariable “core” 5-bp sequence had to be present. In this
fashion, we reduced the number to 2,879 motifs in retinal
endothelial sequences and 2,597 motifs in choroidal
endothelial sequences, corresponding to 146 and 147
transcription factors, respectively. A total of 135 transcrip-
tion factors were identified in both retinal and choroidal
endothelial sequences, while 23 transcription factors were
identified in relation to either retinal or choroidal endothe-
lial, but not both, sequences. Transcription factors and
corresponding motif consensus core sequences (defined by
International Union of Pure and Applied Chemistry
[IUPAC] nucleotide code) [19] that were most abundant
in retinal endothelial promoter sequences were (1) zinc
finger 5 (ZF5), CGCGC (n=140); (2) avian myeloblastosis
viral oncogene homolog (v-Myb), AACGG (n=112); (3)
Hand1:E47, TCTGG (n=91); (4) epidermal growth factor
receptor-specific transcription factor (ETF), GGCGG (n=
87); and (5) transcription factor AP-2 (TFAP2), CMSGC
(n=72). Transcription factors and motif consensus core
sequences that were most abundant in choroidal endothelial
promoter sequences were (1) ZF5, CGCGC (n=179); (2)
ETF, GGCGG (n=106); (3) v-Myb, AACGG (n=89); (4)
MYC-associated zinc finger protein (MAZ), GGGAG (n=
75); (5) and Hand1:E47, TCTGG (n=71). Table 1 shows
the distribution of binding sites by strand and by location.
The transcription binding sites were located approximately
1:1, forward strand/reverse strand and approximately 3:2,
2,000 bp upstream/1,000 bp downstream of the TSS.
We used Fisher’s exact test to compare the abundance of
cis-regulatory motifs, corresponding to each of the tran-
scription factors identified in the previous analysis, in the
promoter regions of differentially expressed retinal and
choroidal endothelial genes. Before testing, for genes
having transcript variants with different TSSs, we collapsed
a l li s o f o r m si n t oo n ee n t r yb yt a k i n gt h em a x i m u m
frequencies of each motif identified for any isoform. For
five transcription factors, motifs were significantly more
abundant in retinal endothelial promoter sequences. Tran-
scription factors and corresponding motif consensus core
sequences (defined by IUPAC nucleotide code) [19] were
(1) glucocorticoid receptor (GCCR; p=0.015), GTTCT; (2)
high mobility group AT-hook 1 (HMGIY; p=0.022),
GGAAA; (3) heat shock transcription factor 1 (HSF1;
p=0.025), AGAAY; (4) p53 (p=0.025), CATGY; and (5)
vitamin D receptor (VDR; p=0.024), GGGTS and
TGAMC. Motifs recognized by three transcription factors




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































40 j ocul biol dis inform (2008) 1:37–45were significantly more abundant in choroidal endothelial
promoter sequences. These transcription factors and motif
consensus core sequences were (1) transcription factor E2F
(E2F; p<0.001), TGGCG and CGGCA; (2) Yin Yang 1
(YY1; p=0.001), GCCAT; and (3) ZF5 (p=0.006),
CGCGC. In addition, the analysis identified motifs recog-
nized by TFAP2 as being more abundant in retinal
endothelial promoter sequences, and, simultaneously, it
identified motifs recognized by TFAP2-alpha as being
more abundant in choroidal endothelial promoter sequen-
ces; as TFAP2-alpha is a member of the TFAP2 family, we
attributed this result to a database anomaly and did not
consider it valid for further consideration. Supplementary
Table 3 presents the total number of motifs in retinal and
choroidal endothelial promoter sequences corresponding to
the eight transcription factors identified as described above.
Figure 1 illustrates graphically the relative frequencies of
motifs recognized by these transcription factors.
Identification of putative cis-regulatory modules in genes
differentially expressed by retinal and choroidal endothelial
cells
We next employed CisModule to identify potential cis-
regulatory modules, comprised of up to five cis-regulatory
motifs, in the promoter regions of differentially expressed
retinal and choroidal genes. The algorithm detected 220
representations of a putative module in retinal endothelial
sequences and 441 representations of a putative module in
choroidal endothelial sequences. The predicted cis-regulatory
modules for promoter sequences in genes highly expressed
by retinal or choroidal endothelial cells were different.
Table 2 shows the predicted modules for retinal and
choroidal sequences and possible identities for respective
constituent cis-regulatory motifs, obtained by submitting the
motif sequences to TRANSFAC Professional. Nine of the
ten predicted motifs were identified, and there was one novel
motif. Among the 67 genes that were more highly expressed
in retinal endothelial cells, 54 genes (81%) were identified as
containing one or more of the predicted modules, while 63 of
63 genes (100%) that were more highly expressed in
choroidal endothelial cells were similarly identified. Table 3
presents these data and indicates the number of motifs that
composed the predicted retinal and choroidal endothelial
modules. Supplementary Tables 4 and 5 give the position
weight matrices of the predicted motifs with consensus
sequences, and Fig. 2 shows the sequence logos. A sequence
logo is a graphical representation of a sequence; at any given
position, the height of each letter within a stack indicates the
relative frequency of the corresponding nucleotide, and the
total height of stack at any given position indicates how
informative that position is within the binding site [20].
Discussion
Previously, we compared the relative abundance of gene
transcripts between endothelial cells isolated from retina
and choroid by microarray, to characterize vascular endo-
thelial diversity within the eye [3]. In this study, we utilized
a computational approach to identify cis-regulatory motifs
and transcription factors that might account for the differ-
ences in gene expression we observed. Particular cis-
regulatory motifs may cluster together within a promoter
region as modules that control cell-specific gene expression
on the binding of transcription factors [5]. Using the
TRANSFAC database and the CisModule software, we
have identified a number of cis-regulatory motifs and
modules that appear to regulate gene expression in either
retinal or choroidal endothelial cells. Identification of such
promoter elements may have implications for the patho-
genesis of diseases that specifically involve these endothe-
lial cells, including proliferative diabetic retinopathy and
neovascular age-related macular degeneration (AMD).
Mitochondrial dysfunction, overproduction of vascular
endothelial growth factor (VEGF), and endothelial cell
proliferation are key events in the pathogenesis of choroidal
neovascularization in AMD [21, 22]. Interestingly, cis-
regulatory motifs for E2F, YY1, and ZF5 are prevalent in
promoters of genes that are preferentially expressed in
choroidal endothelial cells. All three transcription factors
could potentially influence directly or, via a signaling
pathway, one or more of the aforementioned events. When
Fig. 1 Relative frequency of cis-regulatory motifs that were signif-
icantly over-represented within the promoters of genes differentially
expressed by retinal versus choroidal endothelial cells. Frequency was
determined with respect to total number of cis-regulatory motifs
within all genes studied for each cell subtype. Motifs are identified
according to the corresponding transcription factors (GCCR glucocor-
ticoid receptor, HMGIY high mobility group AT-hook 1, HSF1 heat
shock transcription factor 1, VDR vitamin D receptor, E2F transcrip-
tion factor E2F, YY1 Yin Yang 1, ZF5 zinc finger 5)
j ocul biol dis inform (2008) 1:37–45 41 41neovascularization is induced in the E2F1 gene-deficient
mouse, either by hind limb ischemia or tumor challenge,
vascular proliferation is exacerbated, as a result of the
production of excess VEGF; E2F1 interacts with p53 under
hypoxic conditions to repress VEGF transcription [23]. In
the mouse, ZF5 represses transcription of the myc gene
[24], whose product regulates the activity of specific
members of the E2F family of proteins to induce either
cell proliferation or cell death [25]. Loss of cellular YY1
leads to a diminution of mitochondrial oxidative function
via a pathway involving the mammalian target of rapamy-
cin (mTOR) [26]. Overexpression of mTOR augments the
activity of hypoxia-inducible factor (HIF)-1 alpha, and
secretion of VEGF under conditions of low oxygen tension,
thereby increasing the growth of new vessels [27].
Dysregulation of the transcription factors that interact with
E2F, YY1, and ZF5, or polymorphisms within the cis-
regulatory motifs themselves, might influence the onset or
progression of neovascular AMD.
cis-Regulatory motifs that are more prevalent in the
promoters of genes preferentially expressed in retinal
endothelial cells (i.e., GCCR, HMGIY, HSF1, p53, and
VDR) interact with transcription factors that regulate cell
proliferation, apoptosis, aging, and the stress response; all
these processes are pertinent to neovascularization in
diabetic retinopathy. Transcription factor, HSF1, is regulat-
ed in response to cellular stress and promotes the removal
of accrued unfolded peptides from the endoplasmic
reticulum [28]. This process may be perturbed in diabetes
mellitus [29]. As proliferative diabetic retinopathy involves
Table 2 Predicted cis-regulatory modules and constituent motifs, with possible identities of corresponding transcription factors as determined by
TRANSFAC Professional, for genes that were highly expressed by human retinal or choroidal endothelial cells
Motif or Module Consensus sequence Total number Possible transcription factor
Genes with ↑ expression in retinal EC Motif 1 GTCCCTGGGCTCTG 159 GATA4
Motif 2 CCAGCGGCGCCCAG 398 ZF5
Motif 3 GGGTGGGGTGGGGG 105 SREBF1
Motif 4 CAGGGGCAGGAGG 249 Unidentified
Motif 5 GGGGGGGGGCAGGG 591 ZBTB7
Module 221
Genes with ↑ expression in choroidal EC Motif 1 AAAAAAAAAATAAA 849 TBP
Motif 2 AAAAAAAAAAAAAA 254 FALZ
Motif 3 CCTCTCCCCCCCCC 511 WT1
Motif 4 TGTGTGTGTGTGTG 153 Pax-4
Motif 5 CCCCGCGCTCCCCC 1,229 WT1
Module 441
If TRANSFAC Professional identified multiple transcription factors that could bind to a particular consensus sequence, the factor with core match
and matrix match equal to or closest to one was selected for presentation.
EC endothelial cell, GATA-4 GATA-binding factor 4, ZF5 zinc finger 5, SREBF1 sterol regulatory element-binding factor 1, ZBTB7 zinc finger-
and BTB domain-containing protein 7, TBP TATA box-binding protein, FALZ fetal Alzheimer antigen, WT1 Wilms’ tumor zinc finger protein,
Pax-4 paired box gene 4
Table 3 Number of predicted cis-regulatory modules and motifs in promoter sequences of genes that were differentially expressed by human
retinal and choroidal endothelial cells
Promoter sequence Number (% of total)
Module Motif 1 Motif 2 Motif 3 Motif 4 Motif 5
Genes with ↑ expression in retinal EC Genes 53 42 32 52 52 54
(67 total) 79% 63% 48% 78% 78% 81%
Genes + isoforms
a 69 57 46 62 64 68
(91 total) 76% 63% 51% 68% 70% 75%
Genes with ↑ expression in choroidal EC Genes 63 49 63 51 49 58
(63 total) 100% 78% 100% 81% 78% 92%
Genes + isoforms
a 75 60 72 62 62 70
(76 total) 99% 79% 95% 82% 82% 92%
EC endothelial cell
aPromoter sequences corresponding to transcript isoforms with alternative TSSs were included in this analysis
42 j ocul biol dis inform (2008) 1:37–45abnormal growth of retinal blood vessels, it is intriguing
that a low level of HMGA1 leads to a decrease of cell-
surface insulin receptors in patients with insulin resistance
and type II diabetes [30]. Moreover, an overproduction of
HMGA1 protein can lead to cell proliferation and inhibition
of apoptosis mediated by p53 [31]. p53 has many activities,
including induction of apoptosis in cells with damaged
DNA, anti-oxidative effects with implications for the
reduction of oxidative damage associated with aging, and
anti-angiogenic effects via inhibition of HIF-1 alpha [32,
33]. The carboxyl region of VDR binds the active form of
vitamin D, while the amino region binds to the cis-
regulatory motif [34]. Activation of VDR by vitamin D
prevents the proliferation of endothelial cells isolated from
tumors [35], and, consistent with this observation, vitamin
D treatment inhibits angiogenesis in a mouse model of
retinoblastoma [36]. Interestingly, a polymorphism within
the VDR gene, believed to alter the ability of the activity of
the transcription factor, is associated with type I diabetes
[37]. Like VDR, GCCR is a hormone-activated transcrip-
tion factor [38]. Activation of GCCR also suppresses
neoplasia-associated angiogenesis in vivo, an effect that
results from decreased levels of VEGF and interleukin-
8[ 39]. Interestingly, both VDR and GCCR are differen-
tially expressed by different extraocular endothelial cell
subpopulations [40, 41].
As with any in silico research, it will be important to
confirm findings in in vitro and/or in vivo biological
systems. For example, one might construct reporter vectors
containing multiple copies of a cis-regulatory motif or a
combination of these motifs for transfection of retinal and
choroidal endothelial cells, to evaluate cell-specific inter-
actions of transcription factor(s) and promoter element(s). It
is also important to be aware that the output from a
computational study of this nature depends very much on
the selection of sequences for analysis. For example, we
initially performed analysis of the same genes that were
used for the present study, with Promoter Analysis and
Interaction Network Tool (PAINT) v3.5 [35], an alternative
program for identifying cis-regulatory motifs within a
Fig. 2 Sequence logos for predicted cis-regulatory modules in a genes that were expressed at significantly higher levels in retinal endothelial cells
and b genes that were expressed at significantly higher levels in choroidal endothelial cells
j ocul biol dis inform (2008) 1:37–45 43 43genomic sequence. PAINT predicts the TSS position along
the gene sequence and identifies cis-regulatory motifs
upstream of this forecasted site [42]. In the pilot study with
PAINT, we examined the 2,000-bp upstream region of the
predicted TSS and obtained a different set of cis-regulatory
motifs to those identified in this project (data not shown). In
the current study, we analyzed both 2,000-bp downstream
and 1,000-bp downstream of the predicted TSS, as
sequences downstream of the TSS, including intronic
sequences, may contain cis-regulatory elements [43]. In
addition, we more accurately determined the position of the
TSS by manually collecting promoter sequences from
the literature. The same general principles apply to the
prediction of cis-regulatory modules by CisModule. An
apparent contradiction is that cis-regulatory motifs recog-
nized by ZF5 were more abundant in genes highly
expressed by choroidal endothelial cells and, yet, also
present within a predicted retinal endothelial cis-regulatory
module (Table 2). However, the result of the CisModule
analysis implies that ZF5 may preferentially regulate gene
expression in retinal endothelial cells only when acting in
concert with other transcription factors. One novel putative
motif was identified within the retinal cis-regulatory
module (Table 2). If nuclear protein extract isolated from
retinal endothelial cells specifically binds this novel motif,
it would be of immediate interest to identify the corre-
sponding transcription factor(s).
Identifying and characterizing retinal and choroidal
endothelial cell-specific gene expression may have impli-
cations for the treatment of vascular diseases of the eye.
Regarding the proliferating choroidal endothelial cells
responsible for neovascular AMD, the logical goal of
treatment is to inhibit division and/or induce apoptosis of
these cells alone. The same reasoning applies to retinal
endothelial cells and diabetic retinopathy. Delivery of a
therapeutic transgene under the control of a promoter with
cis-regulatory motifs that are preferentially activated in one
endothelial population could potentially enhance gene
expression exclusively in those cells, avoiding detrimental
effects to neighboring non-diseased cells, including other
endothelial populations. Retinal cell-specific promoters and
enhancers have been characterized and used to achieve cell-
specific expression within the retina [44, 45]. Endothelial
cell-specific promoter elements isolated from the human
VEGF-R1 gene effectively target transgene expression to
the ocular vasculature when injected intravitreally [46], and
enhancer elements that specifically limit expression to
proliferating endothelial cells have been identified [47]. A
promoter construct that combines specific retinal or
choroidal endothelial cis-regulatory motifs and element(s)
that initiate expression in proliferating cells could provide a
safe and effective new treatment for proliferative diabetic
retinopathy or neovascular AMD, respectively.
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